Showing results (991-1000 of 1,155) with videos related to

Sort By:
Pageof 116
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2026
Extended thromboprophylaxis in enhanced recovery after surgery for colorectal cancer: a multicentre retrospective cohort studyS T Glazemakers, S H J Ketelaers, H B Cornelisse, et al.
Praxis|May 28, 2025
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate CancerArnoud J Templeton, Vérane Achard, Dilara Akhoundova, et al.
Annals of Surgical Oncology|February 5, 2021
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)Koen P Rovers, Emma C E Wassenaar, Robin J Lurvink, et al.
Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.
Nature Communications|April 11, 2024
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbitsAnnemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
The Lancet. Respiratory Medicine|November 17, 2019
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trialConor D Tweed, Rodney Dawson, Divan A Burger, et al.
JCO Precision Oncology|September 14, 2020
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian CancerYing L Liu, Pier Selenica, Qin Zhou, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2026
Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in patients with High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT TrialE Banken, K van den Berg, I E G van Hellemond, et al.
American Journal of Hematology|September 13, 2019
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphomaTalha Munir, Jennifer R Brown, Susan O'Brien, et al.
Pageof 116